Antenatal corticosteroids and outcomes of preterm small-for-gestational-age neonates in a single medical center.

Woo Jeng KimYoung Sin HanHyun Sun KoIn Yang ParkJong Chul ShinJeong Ha Wie

Published in: Obstetrics & gynecology science (2017)

ACS did not improve neonatal morbidities, in SGA neonates delivered between 29 and 34 gestational weeks. Rather, ACS could increase the risk of RDS. In cases of SGA neonate delivered between 32 and 34 complete gestational weeks, the risk of hypoglycemia was significantly increased. The use of ACS in women with preterm SGA infants needs to be evaluated further, especially after 32 weeks' gestation.

Keyphrases

gestational age
birth weight
preterm birth
low birth weight
acute coronary syndrome
pregnant women
weight gain
type diabetes
glycemic control
preterm infants
pregnancy outcomes
metabolic syndrome
physical activity